BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20103787)

  • 1. Detection of tumor-associated neoangiogenesis by Doppler ultrasonography during early-stage ovarian cancer in laying hens: a preclinical model of human spontaneous ovarian cancer.
    Barua A; Bitterman P; Bahr JM; Bradaric MJ; Hales DB; Luborsky JL; Abramowicz JS
    J Ultrasound Med; 2010 Feb; 29(2):173-82. PubMed ID: 20103787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGFR2-Targeted Ultrasound Imaging Agent Enhances the Detection of Ovarian Tumors at Early Stage in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer.
    Barua A; Yellapa A; Bahr JM; Machado SA; Bitterman P; Basu S; Sharma S; Abramowicz JS
    Ultrason Imaging; 2015 Jul; 37(3):224-37. PubMed ID: 25294846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of interleukin 16 with the development of ovarian tumor and tumor-associated neoangiogenesis in laying hen model of spontaneous ovarian cancer.
    Yellapa A; Bahr JM; Bitterman P; Abramowicz JS; Edassery SL; Penumatsa K; Basu S; Rotmensch J; Barua A
    Int J Gynecol Cancer; 2012 Feb; 22(2):199-207. PubMed ID: 22274315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of ovarian tumor detection with αvβ3 integrin-targeted ultrasound molecular imaging agent in laying hens: a preclinical model of spontaneous ovarian cancer.
    Barua A; Yellapa A; Bahr JM; Machado SA; Bitterman P; Basu S; Sharma S; Abramowicz JS
    Int J Gynecol Cancer; 2014 Jan; 24(1):19-28. PubMed ID: 24304684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced sonography depicts spontaneous ovarian cancer at early stages in a preclinical animal model.
    Barua A; Bitterman P; Bahr JM; Basu S; Sheiner E; Bradaric MJ; Hales DB; Luborsky JL; Abramowicz JS
    J Ultrasound Med; 2011 Mar; 30(3):333-45. PubMed ID: 21357555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of Ovarian Tumor Detection by DR6-Targeted Ultrasound Imaging Agents in Laying Hen Model of Spontaneous Ovarian Cancer.
    Barua A; Edassery SL; McNeal S; Bahr JM; Bitterman P; Basu S; Sharma S; Abramowicz JS
    Int J Gynecol Cancer; 2016 Oct; 26(8):1375-85. PubMed ID: 27465898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of ovarian tumors in chicken by sonography: a step toward early diagnosis in humans?
    Barua A; Abramowicz JS; Bahr JM; Bitterman P; Dirks A; Holub KA; Sheiner E; Bradaric MJ; Edassery SL; Luborsky JL
    J Ultrasound Med; 2007 Jul; 26(7):909-19. PubMed ID: 17592054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 16- (IL-16-) Targeted Ultrasound Imaging Agent Improves Detection of Ovarian Tumors in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer.
    Barua A; Yellapa A; Bahr JM; Adur MK; Utterback CW; Bitterman P; Basu S; Sharma S; Abramowicz JS
    Biomed Res Int; 2015; 2015():567459. PubMed ID: 26161406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer.
    Barua A; Bitterman P; Abramowicz JS; Dirks AL; Bahr JM; Hales DB; Bradaric MJ; Edassery SL; Rotmensch J; Luborsky JL
    Int J Gynecol Cancer; 2009 May; 19(4):531-9. PubMed ID: 19509547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic Ovarian Condition May Be a Risk Factor for Ovarian Tumor Development in the Laying Hen Model of Spontaneous Ovarian Cancer.
    Lee HJ; Bahr JM; Bitterman P; Basu S; Sharma S; Abramowicz JS; Barua A
    J Immunol Res; 2018; 2018():2590910. PubMed ID: 30596106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor.
    Hata K; Fujiwaki R; Nakayama K; Maede Y; Fukumoto M; Miyazaki K
    Anticancer Res; 2000; 20(5C):3941-9. PubMed ID: 11268481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer.
    Paris EA; Bahr JM; Bitterman P; Basu S; Abramowicz JS; Barua A
    PLoS One; 2021; 16(7):e0255007. PubMed ID: 34314463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 16 expression changes in association with ovarian malignant transformation.
    Yellapa A; Bitterman P; Sharma S; Guirguis AS; Bahr JM; Basu S; Abramowicz JS; Barua A
    Am J Obstet Gynecol; 2014 Mar; 210(3):272.e1-10. PubMed ID: 24380743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian Cancer: Applications of Chickens to Humans.
    Barua A; Bahr JM
    Annu Rev Anim Biosci; 2022 Feb; 10():241-257. PubMed ID: 35167319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of death receptor 6 by ovarian tumors in laying hens, a preclinical model of spontaneous ovarian cancer.
    Barua A; Yellapa A; Bahr JM; Abramowicz JS; Edassery SL; Basu S; Rotmensch J; Bitterman P
    Transl Oncol; 2012 Aug; 5(4):260-8. PubMed ID: 22937178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cells in the normal ovary and spontaneous ovarian tumors in the laying hen (Gallus domesticus) model of human ovarian cancer.
    Bradaric MJ; Penumatsa K; Barua A; Edassery SL; Yu Y; Abramowicz JS; Bahr JM; Luborsky JL
    PLoS One; 2013; 8(9):e74147. PubMed ID: 24040191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.
    Willmann JK; Lutz AM; Paulmurugan R; Patel MR; Chu P; Rosenberg J; Gambhir SS
    Radiology; 2008 Sep; 248(3):936-44. PubMed ID: 18710985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging.
    Deshpande N; Ren Y; Foygel K; Rosenberg J; Willmann JK
    Radiology; 2011 Mar; 258(3):804-11. PubMed ID: 21339349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral blood flow analysis in ovarian cancer: what does it mean?
    Hata K; Hata T
    J Ultrasound Med; 1996 Aug; 15(8):571-5. PubMed ID: 8839404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.